Stay updated on ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page footer revision/version has been updated from v3.5.2 to v3.5.3, indicating a maintenance or release update without changing the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-25T06:13:22.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:51:05.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-20T05:50:56.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:43:39.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed on the page. The previously displayed lapse-in-funding notice and the Revision: v3.4.1 entry have been removed.
    Difference
    0.2%
    Check dated 2026-02-11T14:29:31.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    A site-wide funding notice banner was added, informing users about a lapse in government funding and directing them to cc.nih.gov and opm.gov for status. The page revision now shows v3.4.1, replacing v3.4.0.
    Difference
    0.2%
    Check dated 2026-02-04T10:44:44.000Z thumbnail image

Stay in the know with updates to ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.